If you can spare a few minutes, please help us improve our website by completing this survey.
May 28, 2014
A team led by KI faculty member Darrell Irvine, along with Dana-Farber Cancer Institute investigators Kai Wucherpfennig and Michael Goldberg, received the Melanoma Research Alliance (MRA) Team Science Award to optimize T cell-targeting nanoparticles for improved melanoma treatment. The Team Science Award Program is the centerpiece of the MRA research funding portfolio and aims to promote collaborative, interdisciplinary, transformational melanoma research advances with the potential for rapid clinical translation. As such, it is no surprise that this team came together through the Bridge Project, a collaboration between the Koch Institute and Dana-Farber/Harvard Cancer Center designed to unite bioengineering, advanced cancer science, and clinical oncology to solve challenging problems in cancer research and care. The team's project was among the ten finalists in this year’s round of Bridge Project funding, and speaks to the power of the Bridge Project to establish new connections between unmet clinical needs and innovative technological solutions. Congratulations!